Yutaka Hirasawa

Circulating KL-6 Predicts the Outcome of Rapidly Progressive Idiopathic Pulmonary Fibrosis

Akihito Yokoyama, Nobuoki Kohno, Hironobu Hamada et al. · American Journal of Respiratory and Critical Care Medicine · 1998 · 210 citations

Heart Failure, Antifibrotic Therapy, Inflammatory Lung Disease +16

KL-6, a Human MUC1 Mucin, Is Chemotactic for Human Fibroblasts

Yutaka Hirasawa, Nobuoki Kohno, Akihito Yokoyama et al. · American Journal of Respiratory Cell and Molecular Biology · 1997 · 177 citations

Inflammatory Lung Disease, Muc1 Mucin, Lung Inflammation +24

Natural Autoantibody to MUC1 Is a Prognostic Indicator for Non–Small Cell Lung Cancer

Yutaka Hirasawa, Nobuoki Kohno, Akihito Yokoyama et al. · American Journal of Respiratory and Critical Care Medicine · 2000 · 126 citations

KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts

Shinichiro Ohshimo, Akihito Yokoyama, Noboru Hattori et al. · Biochemical and Biophysical Research Communications · 2005 · 108 citations

Inflammatory Lung Disease, Cell Regulation, Lung Inflammation +12

Circulating Levels of Soluble Interleukin-6 Receptor in Patients with Bronchial Asthma

Akihito Yokoyama, Nobuoki Kohno, Kimiko Sakai et al. · American Journal of Respiratory and Critical Care Medicine · 1997 · 61 citations

Asthma, Environmental Allergy, Inflammatory Lung Disease +17